Brevera Breast Biopsy System BREV200Recalls & reported problems
Hologic, Inc. · Vacuum-assisted biopsy device used to remove breast tissue in a minimally invasive manner using stereotactic or tomosyntheses imaging. · Class 2
All models of Brevera Breast Biopsy System (5)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 7
- Deaths reported
- 0
- Injuries reported
- 3
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 7 adverse event reports that list this exact device (DI 15420045507753), received between Jun 9, 2022 and Dec 29, 2025 — classified as 3 injuries, 4 malfunctions.
The most frequently reported specific device problem is “Failure to Obtain Sample” (3 reports).
1 other recall cover devices cleared under the same FDA submission (K163052); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Failure to Obtain Sample3
- Computer Software Problem2
- Appropriate Device Problem Term/Code Not Available1
- Communication or Transmission Problem1
Patient problems
- No Clinical Signs, Symptoms or Conditions7
Recent adverse event reports
The 7 most recent of 7 reports, in the reporter's own words as published by the FDA.
MalfunctionDec 29, 2025Failure to Obtain Sample; Failure to Obtain Sample
IT WAS REPORTED THAT DURING A BREVERA BREAST BIOPSY PROCEDURE ON (B)(6) 2025, THE USER REPORTS THAT THE DEVICE WAS NOT INITIALLY OBTAINING ANY TISSUE SAMPLES WHEN THE NEEDLE WAS IN THE PATIENT'S BREAST. THE USER FURTHER REPORTS THAT THE NEEDLE WAS REPLACED, NEEDLE TESTS WERE PERFORMED, BUT WHEN THE NEEDLE WAS INSERTED INTO THE PATIENT, A DEVICE DRIVER ERROR WAS DISPLAYED. THE USER COMPLETED THE PROCEDURE USING ANOTHER DEVICE. A FIELD SERVICE ENGINEER WAS DISPATCHED TO EXAMINE THE DEVICE AND REPORTS, "DRIVER ISSUE WHEN USING ON PATIENT, CUSTOMER FOUND DEBRIS INSIDE NEEDLE." THE FSE WAS UNABLE TO DETERMINE IF THE DISPOSABLE NEEDLE OR THE DRIVER WAS THE CAUSE OF THE DEVICE ERROR; THEREFORE, THE DRIVER WAS REPLACED. NO FURTHER INFORMATION IS CURRENTLY AVAILABLE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23916791 ↗InjuryOct 27, 2025Communication or Transmission Problem; Communication or Transmission Problem
IT WAS REPORTED BY THE USER SITE THAT DURING A BREVERA BREAST BIOPSY PROCEDURE ON (B)(6) 2025, AN ISSUE OCCURRED IN WHICH THE DEVICE INDICATED THAT THE FILTER WAS NOT RECOGNIZED DESPITE THE DEVICE SUCCESSFULLY PASSING PRE-PROCEDURE TESTING. IT IS REPORTED THAT THE NEEDLE WAS REMOVED FROM THE PATIENT AND THE PROCEDURE WAS ABORTED. A FIELD SERVICE ENGINEER (FSE) WAS DISPATCHED TO EXAMINE THE DEVICE AND DETERMINED THAT THE CORLUMINA NEEDED TO BE REPLACED. THE FSE REPLACED THE CORLUMINA, COMPLETED REQUIRED CALIBRATIONS AND CONFIRMED THAT THE DEVICE IS FUNCTIONING. NO FURTHER INFORMATION IS CURRENTLY AVAILABLE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23393913 ↗InjuryJan 19, 2024Failure to Obtain Sample; Failure to Obtain Sample
IT WAS REPORTED THAT ON DECEMBER 27TH A BIOPSY PROCEDURE WAS PERFORMED WITH A BREVERA SYSTEM AND THE PHYSICIAN FEEL THAT THE VACUUM ON THE BREVERA SYSTEM WAS NOT WORKING PROPERLY AND AS EXPECTED. DESPITE PRECISE NEEDLE POSITIONING, THEY DID NOT GET ANY CALCIFICATIONS AND THE PATIENT HAD TO BE RESCHEDULED. NO ADDITIONAL INFORMATION AVAILABLE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 18546138 ↗MalfunctionMay 19, 2023Failure to Obtain Sample; Failure to Obtain Sample
IT WAS REPORTED THAT ON (B)(6) 2023, DURING A BREVERA PROCEDURE WHILE THE NEEDLE WAS INSIDE THE PATIENT´S BREAST, THE CONSOLE EXPERIENCED ISSUES WITH THE DRIVER THUS THEY HAD TO REBOOT THE CONSOLED AND COULD NOT OBTAIN THE SAMPLES. DUE TO THIS THE PROCEDURE WAS RESCHEDULED. THE EQUIPMENT WAS EXAMINED AND ISSUES WITH THE COMMUNICATION SOFTWARE WERE FOUND. THE SYSTEM IS SCHEDULED FOR SOFTWARE MAINTENANCE. NO OTHER INFORMATION IS AVAILABLE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 16962003 ↗InjuryOct 7, 2022Appropriate Device Problem Term/Code Not Available; Appropriate Device Problem Term/Code Not Available
ON FRIDAY AFTERNOON THEY HAD A STEREO TO DO ON THE BREVERA. WHEN THE NURSE WENT TO PUT THE SPECIMEN IN THE PATH CONTAINER THERE WAS NO TISSUE IN THE 12-CHAMBER TISSUE FILTER. THEY RESET UP WITH ALL NEW KIT AND TOOK ANOTHER SAMPLE, AGAIN THERE WAS NO TISSUE SAMPLE. NO ERROR CODES OR MESSAGES ARE DISPLAYED ON THE UNIT. THE INVOLVED NEEDLES WERE CUT FROM THEIR TUBING AND DISPOSED OF. NO INJURY, BUT THE PATIENT HAS BEEN RESCHEDULED FOR ANOTHER BIOPSY. NO ADDITIONAL INFORMATION IS AVAILABLE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 15562077 ↗MalfunctionOct 6, 2022Computer Software Problem; Computer Software Problem
IT WAS REPORTED THAT A PATIENT UNDERWENT A BREVERA BIOPSY PROCEDURE ON (B)(6) 2022. THE BREVERA CONSOLE AND THE DISPOSABLE WERE ALL SUCCESSFULLY TESTED. THE NEEDLE WAS THEN INSERTED INTO THE PATIENT BREAST AT THE TARGET, BUT AN ERROR MESSAGE (DEVICE DRIVER LOSS COMMUNICATION) WAS DISPLAYED ON THE CONSOLE; THEREFORE THE BIOPSY WOULD NOT START. THE NEEDLE WAS REMOVED, THE UNIT WAS REBOOTED BUT THIS COULD NOT SOLVE THE ISSUE. THE PROCEDURE WITH BREVERA SYSTEM WAS THEN ABANDONED. THE MEDICAL TEAM DECIDED TO USE ANOTHER METHOD: THE PATIENT WAS REMOVED FROM COMPRESSION, REPOSITIONED AND A NEW TARGET ACQUIRED; A SECOND INCISION WAS MADE AND THE BIOPSY WAS COMPLETED USING ANOTHER BIOPSY DEVICE. NO PATIENT INJURY (OTHER THAN A SECOND INCISION MADE) OR ANY ADVERSE EVENT WAS REPORTED RELATED TO THIS INCIDENT. THE INVOLVED BREVERA NEEDLE WILL NOT BE RETURNED FOR EVALUATION, AS IT WAS DISCARDED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 15555927 ↗MalfunctionJun 9, 2022Computer Software Problem; Computer Software Problem
IT WAS REPORTED THAT DURING A BREVERA PROCEDURE ON MAY 17TH THE CONSOLED DISPLAYED AN ERROR AND THE PROCEDURE HAD TO BE ABORTED AND THE PATIENT REQUIRED TO BE RESCHEDULED. NO ADDITIONAL INFORMATION IS AVAILABLE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 14648713 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K163052. One submission often covers many models, so check the product and lot details in each record.
- Z-1314-2026 · Dec 15, 2025 · Open, ClassifiedBrevera Breast Biopsy System Disposable 9 Gauge Needle. Biopsy Instrument.
Other INSTRUMENT, BIOPSY devices
- MAX-CORE MC1616Bard Peripheral Vascular, Inc. · INSTRUMENT, BIOPSY1 recall4,258 reports
- ENCOR® ECP017GSenorx, Inc. · INSTRUMENT, BIOPSY1 recall4,186 reports
- MAX-CORE MC1820Bard Peripheral Vascular, Inc. · INSTRUMENT, BIOPSY1 recall2,404 reports
- MAX-CORE MC1816Bard Peripheral Vascular, Inc. · INSTRUMENT, BIOPSY1 recall1 death848 reports
- MAX-CORE MC1410Bard Peripheral Vascular, Inc. · INSTRUMENT, BIOPSY1 recall399 reports
- MAX-CORE MC1610Bard Peripheral Vascular, Inc. · INSTRUMENT, BIOPSY1 recall394 reports
- ENCOR® ECP0110GVSenorx, Inc. · INSTRUMENT, BIOPSY392 reports
- ENCOR® ECP0110GSenorx, Inc. · INSTRUMENT, BIOPSY390 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page